Pramlintide
APP
AstraZeneca · Not applicable · Recruiting · Enrollment 18
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Amylin (Pramlintide) + Placebo | n/r | n/r | n/r | n/r |
| PP + Placebo | n/r | n/r | n/r | n/r |
| Amylin (Pramlintide) + PP | n/r | n/r | n/r | n/r |
| Placebo + Placebo | n/r | n/r | n/r | n/r |
Not shown
- Amylin (Pramlintide) + Placebo: endpoint not reported
- PP + Placebo: endpoint not reported
- Amylin (Pramlintide) + PP: endpoint not reported
- Placebo + Placebo: endpoint not reported